Evidence map›Paper›PMID 27044586›Full record

ArticleBMJ open2016

Patient attitudes about the clinical use of placebo: qualitative perspectives from a telephone survey.

Robin Ortiz, Sara Chandros Hull, Luana Colloca

Registry-linked trialOpen access · goldAbstract read
In one paragraph

Article in BMJ open, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT03294148 (Mind-body Treatments for Chronic Back Pain), which is not on this map. Cited by 15 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed, 1 pooled it
2.2field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT03294148 nacompletednot on this mapstarted 2017, after this paper: background citation

Mind-body Treatments for Chronic Back Pain

TypeinterventionalSponsorUniversity of Colorado, BoulderRan2017 to 2019Enrolled151ConditionsChronic Pain, Back Pain Lower Back Chronic, Back Pain, LowArmsOpen-Label Placebo Treatment for Chronic Back Pain, Psychotherapy Treatment for Chronic Back Pain
3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 1 synthesis or guideline pooled it, 33 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 2 institutions in 1 country.

Robin OrtizMedicine-Pediatrics Residency Program, Johns Hopkins Hospital, Baltimore, MD and National Institutes of Health, Bethesda, Maryland, USA.
Sara Chandros HullNational Institutes of Health and Department of Bioethics, Office of the Scientific Director, National Human Genome Research Institute, Clinical Center, National Institutes of Health, Bethesda, Maryland, USA.
Luana CollocaDepartment of Pain Translation Symptom Science; School of Medicine, Department of Anesthesiology, University of Maryland, School of Nursing, Center to Advance Chronic Pain Research (CACPR), Baltimore, Maryland, USA.
National Institutes of Health · USUniversity of Maryland, Baltimore · US

Funding

Chronic orofacial pain: genetics, cognitive-emotional factors, and endogenous modulatory systemsR01DE025946 · NIDCR · UNIVERSITY OF MARYLAND BALTIMORE · PI COLLOCA, LUANA · 2016 to 2019
$2.1M
Intramural NIH HHSNIDCR NIH HHS 1R01DE025946-01NIDCR NIH HHS R01 DE025946
6 · The paper itself

Abstract

objectivesTo examine qualitative responses regarding the use of placebo treatments in medical care in a sample of US patients.Survey studies suggest a deliberate clinical use of placebos by physicians, and prior research has found that although most US patients find placebo use acceptable, the rationale for these beliefs is largely unknown.

settingMembers of the Outpatient Clinic at the Kaiser Permanente Northern California interviewed research participants who had been seen for a chronic health problem at least once in the prior 6 months.

participants853 women (61%) and men, white (58%) and non-white participants aged 18-75 years. PRIMARY AND SECONDARY OUTCOMES: Qualitative responses on perceptions of placebo use from one-time telephone surveys were analysed for common themes and associations with demographic variables.

resultsPrior results indicated that a majority of respondents felt it acceptable for doctors to recommend placebo treatments. Our study found that a lack of harm (n=291, 46.1%) and potential benefit (n=250, 39.6%) were the most common themes to justify acceptability of placebo use. Responses citing potential benefit were associated with higher education (r=0.787; p<0.024). Of the minority of respondents who judged it never acceptable for doctors to recommend placebo treatments, the most often referenced rationale was obligation of the doctor to do more (n=102, 48.3%). Additional themes emerged around the issue of whether a doctor was transparent about placebo use, including honesty, patient's right to know and power of the mind. Older age was associated with likelihood to cite overall physician, as opposed to treatment, related themes (r=0.753; p<0.002).

conclusionsParticipants seem to appreciate and understand the lack of harm and potential benefit associated with placebo treatments, while valuing the role of the physician and the patient in its implementation.

Indexed as

Attitude to HealthComprehensionMind-Body TherapiesPhysician-Patient RelationsPractice Patterns, Physicians'TrustAdolescentAdultAgedCaliforniaChronic DiseaseEducational StatusFemaleHumansMaleMiddle AgedPlacebosDeceptionDoctor-patient relationshipPatients' viewPlaceboPlacebo effectsTrust

Identifiers

PMID27044586
PMCPMC4823468
OpenAlexW2339129642

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.